Durability of Antibody Response Against Hepatitis B Virus for a Decreased Crowd: A Retrospective Polycentric Cohort Study from a 10-Year Follow-Up Clinical Study.

Infect Drug Resist · 2022 · PMC9760075 · PMID 36540103

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

distinctly significantP < 0.001actually significant

Some parameters, such as the HBsAb interval time between descent, antiviral drugs, and first-HBsAb levels, were different ( P < 0.05), and previous HBV history was distinctly significant ( P < 0.001)( Figure 4A–C ).

also in 48 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.